Merck KGaA names new board members

28 January 2014
merck-serono-big

E. Merck KG, which combines the financial interests of the Merck family and is general partner of Germany’s Merck KGaA (MRK: DE) with an interest of 70%, announced at this year's General Partners' Meeting, the family partners elected their representatives to the Family Board, which is the supervisory body of E. Merck KG.

Frank Stangenberg-Haverkamp, 65, has been elected as the new Chairman of the 12-member Family Board. Jon Baumhauer, 69, previously Chairman of the Family Board and Chairman of the Executive Board of E. Merck KG, has retired from his offices.

Mr Stangenberg-Haverkamp said: “For decades, Jon Baumhauer has uniquely shaped and successfully led the company and the Merck family of owners. The partners are exceptionally grateful to him for his leadership of the community of family members and for familiarizing the next generation with the company.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical